Africa In The News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa In The News.

Press releases published on November 5, 2026

Nov. 5, 2026

Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Celldex Reports Third Quarter Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 5, 2026

Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Orchestra BioMed Announces Proposed Public Offering

Indeterminate GlobeNewswire

Nov. 5, 2026

What Published Human Trials Show About a Postbiotic in Women Ages 40 to 55

Indeterminate GlobeNewswire

Nov. 5, 2026

USN-USA Urges Action Against Front for the FRN and Armed Group Financing and Conflict Minerals in Eastern Congo

Indeterminate EIN Presswire

Nov. 5, 2026

Brunswick Upsizes Previously Announced LIFE Offering and Concurrent Private Placement for Gross Proceeds of Up to $20 Million

Indeterminate GlobeNewswire

Nov. 5, 2026

Brunswick annonce une augmentation de la taille de son placement sous le régime de la dispense pour financement de l’émetteur coté et son placement privé simultané annoncés précédemment pour un produit brut pouvant atteindre 20 million $

Indeterminate GlobeNewswire

Nov. 5, 2026

Elevar Therapeutics Announces FDA PDUFA Date for Resubmitted New Drug Application for Rivoceranib in Combination With Camrelizumab for Use as a First-line Systemic Treatment for Unresectable or Metastatic Hepatocellular Carcinoma

Indeterminate GlobeNewswire

Nov. 5, 2026

Compounded Semaglutide Cost per Month Stays the Same From 0.25 mg to 2.4 mg at NexLife

Indeterminate GlobeNewswire

Nov. 5, 2026

Altimmune Announces Data from RECLAIM Phase 2 Trial of Pemvidutide in Alcohol Use Disorder Selected as Late-Breaking Oral Presentation at AASLD The Liver Meeting® 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

Rectify Pharmaceuticals Presents Translational Data on RTY-406 at AASLD 2026 Liver Meeting

Indeterminate GlobeNewswire

Nov. 5, 2026

Highland Copper Announces Grant of Stock Options, Restricted Share Units and Deferred Share Units

Indeterminate GlobeNewswire

Nov. 5, 2026

AIM ImmunoTech Highlights Ampligen® Opportunity to Potentially Extend Benefits of RAS-Targeted Therapies in Pancreatic Cancer

Indeterminate GlobeNewswire

Nov. 5, 2026

Critical Metals Corp. Completes Acquisition of European Lithium

Indeterminate GlobeNewswire

Nov. 5, 2026

Sparrow Pharmaceuticals Announces Expansion Cohorts in Phase 2b CAPTAIN-T2D Trial to Evaluate Clofutriben Across the Full Range of Cortisol Levels in Difficult-to-Control Type 2 Diabetes

Indeterminate GlobeNewswire

Nov. 5, 2026

Quoin Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, to Participate in Upcoming November Investor Conferences

Indeterminate GlobeNewswire

Nov. 5, 2026

SCYNEXIS Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire